ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1065

Hypoxia-Inducible Factor-1α: Trigger of Toll-Like Receptor Signalling-Engaged Inflammation in Rheumatoid Arthritis

Fanlei Hu1, Rong Mu1, Jiaxin Zhu1, Wenwei Shao2, Lianjie Shi1, Philip L. Cohen3, Xiaoyan Qiu2 and Zhanguo Li1, 1Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China, 2Department of Immunology, School of Basic Medical Science, Peking University, Beijing, China, 3Rheumatology, Temple University, Philadelphia, PA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: inflammation and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Innate Immunity and Rheumatic Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Hyperplasia of synovial fibroblasts, infiltration with lymphocytes, and tissue hypoxia are the major characteristics of rheumatoid arthritis (RA). Data has confirmed the central role of toll-like receptors (TLRs) in RA. However, much remains unknown regarding the impact of hypoxia on TLR signalling-induced inflammatory response in RA. The aim of this study was to reveal the effect of hypoxia and its regulator hypoxia-inducible factor-1α (HIF-1α) on the inflammatory response in rheumatoid arthritis synovial fibroblast (RASF) upon the recognition of pathogen molecules. 

Methods:

Hypoxia was induced in RASF by incubation with Na2S2O4. TLR3 ligand polyIC, TLR2 ligand PGN, TLR4 ligand LPS, and TLR9 ligand CpG were used to stimulate the cells. Effects of hypoxia on these ligands-induced inflammatory cytokines and matrix metalloproteinases (MMPs) were determined by RT-PCR, realtime PCR, and ELISA. Overexpressing HIF-1α as well as knocking-down its expression by siRNA were used to reveal its fundamental role. RASF-induced inflammatory T cell expansion was determined by flow cytometry, realtime PCR, and ELISA analyses after RASF/T cell coculture.

Results:

Hypoxia potentiated the expression of inflammatory cytokines, MMPs, and VEGF in RASF stimulated by different TLR ligands, especially polyIC, a synthetic mimic of dsRNA from virus or apoptotic cells. HIF-1α played a fundamental role in this synergy. Moreover, overexpression of HIF-1α enhanced RASF-mediated inflammatory T cell expansion, inducing more proinflammatory IFN-γ and IL-17 production.

Conclusion:

Our findings suggest that hypoxia and HIF-1α may function collaboratively with TLR-engaged inflammatory response to excerbrate the pathogenesis of RA, and HIF-1α might serve as a therapeutic target for this disease.


Disclosure:

F. Hu,
None;

R. Mu,
None;

J. Zhu,
None;

W. Shao,
None;

L. Shi,
None;

P. L. Cohen,
None;

X. Qiu,
None;

Z. Li,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hypoxia-inducible-factor-1%ce%b1-trigger-of-toll-like-receptor-signalling-engaged-inflammation-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology